The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: RBC Upgrades IMI And Downgrades Rotork

Tue, 14th Jul 2020 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

CREDIT SUISSE RAISES HALMA PRICE TARGET TO 2530 (2030) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES JOHNSON MATTHEY TARGET TO 3500 (3400) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES CRODA INTERNATIONAL TARGET TO 5100 (4500) PENCE - 'MARKET-PERFORM'

----------

BARCLAYS RAISES FLUTTER PRICE TARGET TO 10500 (10000) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES SMITHS PRICE TARGET TO 1530 (1300) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS STANDARD CHARTERED PRICE TARGET TO 690 (730) PENCE - 'BUY'

----------

GOLDMAN CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 195 (215) PENCE - 'BUY'

----------

GOLDMAN CUTS LLOYDS BANKING PRICE TARGET TO 29 (32) PENCE - 'SELL'

----------

GOLDMAN CUTS BARCLAYS PRICE TARGET TO 135 (150) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS HSBC TO 'BUY' ('CONVICTION BUY LIST') - PRICE TARGET 565 (695) PENCE

----------

DEUTSCHE BANK CUTS BARCLAYS PRICE TARGET TO 135 (208) PENCE - 'BUY'

----------

DEUTSCHE BANK RESUMES STANDARD CHARTERED WITH 'HOLD' - TARGET 415 PENCE

----------

DEUTSCHE BANK RESUMES RBS WITH 'SELL' - TARGET 100 PENCE

----------

DEUTSCHE BANK REINITIATES LLOYDS BANKING WITH 'HOLD' - PRICE TARGET 34 PENCE

----------

DEUTSCHE BANK REINITIATES HSBC WITH 'SELL' - PRICE TARGET 335 PENCE

----------

JPMORGAN RAISES LEGAL & GENERAL TARGET TO 202 (200) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

DEUTSCHE BANK RAISES G4S TO 'BUY' ('HOLD') - TARGET 160 (140) PENCE

----------

DEUTSCHE BANK RESUMES VIRGIN MONEY WITH 'BUY' - TARGET 105 PENCE

----------

JPMORGAN CUTS JOHN WOOD PRICE TARGET TO 400 (590) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES AVON RUBBER PRICE TARGET TO 3510 (2435) PENCE - 'HOLD'

----------

BERENBERG CUTS PRIMARY HEALTH PROPERTIES TO 'HOLD' ('BUY') - TARGET 155 (150) PENCE

----------

BERENBERG CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 200 (190) PENCE

----------

BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 200 (210) PENCE - 'OVERWEIGHT'

----------

RBC RAISES BODYCOTE PRICE TARGET TO 710 (650) PENCE - 'OUTPERFORM'

----------

RBC RAISES MORGAN ADVANCED TO SECTOR PERFORM ('UNDERPERFORM') - TARGET 275 (250) PENCE

----------

RBC CUTS ROTORK TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 275 (265) PENCE

----------

RBC RAISES IMI TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1140 (1000) PENCE

----------

GOLDMAN CUTS VIRGIN MONEY PRICE TARGET TO 95 (100) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HOCHSCHILD MINING TARGET TO 180 (170) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES SPIRENT PRICE TARGET TO 325 (290) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RESUMES MITIE GROUP WITH 'HOLD' - TARGET 43 PENCE

----------

BERENBERG RAISES CONNECT GROUP TO 'BUY' ('HOLD') - TARGET 27 (15) PENCE

----------

DEUTSCHE BANK CUTS FORTERRA PRICE TARGET TO 234 (340) PENCE - 'BUY'

----------

BERNSTEIN CUTS BOOHOO PRICE TARGET TO 350 (480) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS KENMARE RESOURCES PRICE TARGET TO 370 (380) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 1300 (1500) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS HUNTING PRICE TARGET TO 210 (460) PENCE - 'NEUTRAL'

----------

RBC RAISES RESTAURANT GROUP TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 80 (70) PENCE

----------

GOLDMAN CUTS BANK OF IRELAND PRICE TARGET TO 1.75 (2) EUR - 'NEUTRAL'

----------

GOLDMAN CUTS AIB GROUP PRICE TARGET TO 1.80 (2.20) EUR - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2019 10:43

WINNERS & LOSERS SUMMARY: Tullow Oil Up 6% After Reinstating Dividend

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------Smurfit

Read more
13 Feb 2019 10:05

Clinigen bounds upwards on purchase of Proleukin's US rights

(Sharecast News) - Clinigen Group shares jumped on Wednesday after the company signed an agreement with Novartis to acquire the US rights to its Proleukin drug for up to $210m in cash.

Read more
13 Feb 2019 08:42

Clinigen Stock Climbs As It Buys Proleukin's US Rights From Novartis

LONDON (Alliance News) - Pharmaceuticals firm Clinigen Group PLC's shares rose early Wednesday as it announced the purchase of the rights to one of Novartis International AG's were up 12%

Read more
5 Feb 2019 10:49

Clinigen Group Appoints Accountant Nick Keher Chief Financial Officer

LONDON (Alliance News) - Clinigen Group PLC on Tuesday said it appointed Nick Keher as group chief financial officer with effect from March 19.Keher replaces current CFO Martin Abell, who a

Read more
5 Feb 2019 07:56

Clinigen appoints Nick Keher as new CFO

(Sharecast News) - AIM-listed pharmaceutical and services company Clinigen Group has appointed Nick Keher as its new chief financial officer with effect from 19 March.

Read more
15 Jan 2019 09:37

Clinigen Outlook Confident As Revenue And Profit Grow In First Half

LONDON (Alliance News) - Clinigen Group PLC on Tuesday expressed confidence in delivering progress in its full financial year after it saw a strong earnings growth in the first half.The for

Read more
15 Jan 2019 09:22

Acquisitions spur Clinigen to profit and revenue growth

(Sharecast News) - Clinigen Group on Tuesday reported that, following a series of acquisitions, it expects to report a sharp rise in revenue and profit when it publishes its half-year results next month.

Read more
1 Nov 2018 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Friday 2 NovemberMurgitroyd GroupMonday 5 NovemberRandgold Resources (re Barrick Gold

Read more
27 Sep 2018 17:45

UPDATE: Clinigen In Placing For Two New Purchases; Earnings Jump (ALLISS)

LONDON (Alliance News) - Clinigen Group PLC on Thursday said it placed 9.5 million shares at a price of 845 pence each, raising GBP80 million.The stock closed 11% lower on Thursday at per a

Read more
27 Sep 2018 12:14

Thursday broker round-up

(Sharecast News) - Thomas Cook Group: UBS upgrades to neutral with a target price of 60p.

Read more
27 Sep 2018 10:05

Clinigen In Share Placing For Two New Purchases; Annual Earnings Jump (ALLISS)

LONDON (Alliance News) - Clinigen Group PLC on Thursday announced a share placing to help pay for the acquisition of packaging and distribution services company CSM Parent Inc for up to USD240 in

Read more
27 Sep 2018 08:04

Clinigen announces two new acquisition targets following 'another year of good progress'

(Sharecast News) - Clinigen plans to raise £80m from investors to fund two new acquisitions following a "strong performance" from one of its previous additions in its last trading year.

Read more
20 Sep 2018 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 21 September Smiths GroupFull Year ResultsSIGHalf Year SaatchiHalf Year +

Read more
25 Jul 2018 14:40

Clinigen makes second July drug acquisition

(Sharecast News) - Pharmaceutical and services company Clinigen has acquired the global rights to severe malignant osteoperosis treatment Imukin from Horizon Pharma for an undisclosed sum.

Read more
25 Jul 2018 09:48

Clinigen Acquires Global Rights For Osteoporosis Drug Imukin

LONDON (Alliance News) - Clinigen Group PLC said Wednesday that it acquired the global rights to osteoporosis drug Imukin from Horizon Pharma PLC.The FTSE 250 pharmaceutical company said it

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.